Etodolac (Lodine)
Etodolac
Akromed Products (Pty) Ltd
Registration
- Applicant
- Akromed Products (Pty) Ltd
- Registrations
- 3
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Lodine tablets 200 mg* EACH TABLET CONTAINS ETODOLAC 200 mg | 200 mgTablets | V0044V/2.7/44 | Cancelled | S3 | None |
| Lodine tablets 300 mg* EACH TABLET CONTAINS ETODOLAC 300 mg | 300 mgTablets | V0045V/2.7/45 | Cancelled | S3 | None |
| Lodine capsules 300 mg* EACH CAPSULE CONTAINS ETODOLAC 300 mg | 300 mgCapsules | V0047V/2.7/47 | Registered | S3 | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Etodolac
S3: Etodolac
Consolidated Schedules 06 July 2026, line 3542
Pharmacological class: Antipyretics or antipyretic and anti-inflammatory analgesics. (class 2.7)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
2-(1,8-Diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
Drag to rotate. Structure from PubChem CID 3308.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.